Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Editas Medicine (EDIT) Receivables - Net: 2015-2024

Historic Receivables - Net for Editas Medicine (EDIT) over the last 10 years, with Dec 2024 value amounting to $16.3 million.

  • Editas Medicine's Receivables - Net rose 6352.38% to $8.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.1 million, marking a year-over-year increase of 6352.38%. This contributed to the annual value of $16.3 million for FY2024, which is 59.67% up from last year.
  • According to the latest figures from FY2024, Editas Medicine's Receivables - Net is $16.3 million, which was up 59.67% from $10.2 million recorded in FY2023.
  • Editas Medicine's 5-year Receivables - Net high stood at $16.3 million for FY2024, and its period low was $267,000 during FY2021.
  • In the last 3 years, Editas Medicine's Receivables - Net had a median value of $10.2 million in 2023 and averaged $10.5 million.
  • As far as peak fluctuations go, Editas Medicine's Receivables - Net slumped by 95.59% in 2021, and later surged by 1,826.97% in 2022.
  • Editas Medicine's Receivables - Net (Yearly) stood at $6.0 million in 2020, then slumped by 95.59% to $267,000 in 2021, then soared by 1,826.97% to $5.1 million in 2022, then surged by 98.00% to $10.2 million in 2023, then spiked by 59.67% to $16.3 million in 2024.